Randomised Controlled Clinical Trial to evaluate the effect of a Supervised EXErcise Program on Quality of Life and deliverability of chemotherapy in Patients with Lymphoma treated with chemotherapy.

Dr Fernando Roncolato0 个研究点目标入组 20 人开始时间: 2015年2月2日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Patients with all of the following criteria will be eligible for enrolment:
•a) Aged between 18 and 80 years with biopsy-proven diagnosis of lymphoma, both Hodgkin and non-Hodgkin.
•b) Recommended to have systemic chemotherapy with or without external beam radiotherapy, with curative intent.
•c) Need to have at least half of their recommended number of chemotherapy treatment cycles remaining.
•d) ECOG level 0-2 with adequate cardio-respiratory and musculoskeletal function to participate in a regular exercise program as determined by the consultant physician/investigator.
•e) Ability to read and understand the Patient Information Document and Consent Form with provision of verbal and written consent. Willingness and ability to comply with the specified intervention protocol, follow-up visits and all necessary investigations.

•Patients with any of the following criteria are not eligible for enrolment:
•a) Recommended to either observation or chemotherapy with palliative intent.
•b) Psychiatric disorders which impair ability to give verbal and written consent.
•c) ECOG level 3-4

发起方

Dr Fernando Roncolato